Thomas P. Potjer

1.1k total citations
25 papers, 386 citations indexed

About

Thomas P. Potjer is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Thomas P. Potjer has authored 25 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Thomas P. Potjer's work include Pancreatic and Hepatic Oncology Research (11 papers), Cancer Genomics and Diagnostics (11 papers) and Cutaneous Melanoma Detection and Management (6 papers). Thomas P. Potjer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Cancer Genomics and Diagnostics (11 papers) and Cutaneous Melanoma Detection and Management (6 papers). Thomas P. Potjer collaborates with scholars based in Netherlands, United States and United Kingdom. Thomas P. Potjer's co-authors include Hans F. A. Vasen, Bert A. Bonsing, Martin N.J.M. Wasser, Nienke van der Stoep, Akin Inderson, Saskia Luelmo, J. Sven D. Mieog, Monique E. van Leerdam, Jeanin E. van Hooft and Remco van Doorn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Thomas P. Potjer

21 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas P. Potjer Netherlands	11	268	181	120	69	60	25	386
P. Cusumano Belgium	9	179 0.7×	168 0.9×	79 0.7×	88 1.3×	78 1.3×	20	341
E Patsouris Greece	13	156 0.6×	89 0.5×	166 1.4×	64 0.9×	76 1.3×	31	393
Kazutaka Narui Japan	12	215 0.8×	275 1.5×	153 1.3×	130 1.9×	59 1.0×	81	543
Xiaoli Long China	10	122 0.5×	169 0.9×	140 1.2×	95 1.4×	56 0.9×	24	388
Samuel F. Gilbert United States	9	106 0.4×	250 1.4×	161 1.3×	89 1.3×	124 2.1×	14	436
Seden Küçücük Türkiye	11	131 0.5×	116 0.6×	103 0.9×	26 0.4×	61 1.0×	32	322
Jennifer B. Goldstein United States	10	345 1.3×	130 0.7×	85 0.7×	72 1.0×	177 3.0×	18	438
Borgny Ytterhus Norway	11	178 0.7×	125 0.7×	192 1.6×	19 0.3×	57 0.9×	23	370
Ingirídur Skírnisdóttir Sweden	16	234 0.9×	107 0.6×	176 1.5×	77 1.1×	87 1.4×	26	682
Mina Waraya Japan	15	196 0.7×	122 0.7×	279 2.3×	124 1.8×	44 0.7×	30	514

Countries citing papers authored by Thomas P. Potjer

Since Specialization

Citations

This map shows the geographic impact of Thomas P. Potjer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Potjer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Potjer more than expected).

Fields of papers citing papers by Thomas P. Potjer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Potjer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Potjer. The network helps show where Thomas P. Potjer may publish in the future.

Co-authorship network of co-authors of Thomas P. Potjer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Potjer. A scholar is included among the top collaborators of Thomas P. Potjer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Potjer. Thomas P. Potjer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klatte, Derk C.F., Jeanin E. van Hooft, Remco van Doorn, et al.. (2025). Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant. Molecular Genetics & Genomic Medicine. 13(2). e70045–e70045.

Schrader, Anne M.R., et al.. (2024). Melanoma arising from pre-existing naevus in carriers of a germline CDKN2A pathogenic variant. British Journal of Dermatology. 192(3). 546–548.

Potjer, Thomas P., Paola Del Bianco, Antonella Vecchiato, et al.. (2024). Polygenic Risk Score Improves Melanoma Risk Assessment in a Patient Cohort from the Veneto Region of Italy. Biology. 13(11). 954–954.

Klatte, Derk C.F., Jason S. Starr, Jeanin E. van Hooft, et al.. (2024). Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma. JCO Oncology Practice. 20(8). 1081–1090. 7 indexed citations

Inderson, Akin, Bas Boekestijn, Bert A. Bonsing, et al.. (2024). The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. Pancreas. 53(7). e566–e572. 1 indexed citations

Klatte, Derk C.F., Jeanin E. van Hooft, Remco van Doorn, et al.. (2024). Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial Cancer. 23(3). 255–265. 2 indexed citations

Corssmit, Eleonora P.M., et al.. (2024). SDHAF2-Linked Metastatic Paraganglioma: A Case Report with Implications for Counseling and Follow-Up of Pathogenic SDHAF2 Variant Carriers. SHILAP Revista de lepidopterología. 2024. 1–7. 1 indexed citations

Klatte, Derk C.F., Chris Hinnen, Remco van Doorn, et al.. (2023). Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study. Journal of Genetic Counseling. 33(5). 1059–1069. 4 indexed citations

Klatte, Derk C.F., Bas Boekestijn, Friedo W. Dekker, et al.. (2023). Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis. Gastroenterology. 164(7). 1223–1231.e4. 35 indexed citations

10.

Klatte, Derk C.F., Bas Boekestijn, Martin N.J.M. Wasser, et al.. (2022). Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up. Journal of Clinical Oncology. 40(28). 3267–3277. 60 indexed citations

11.

Potjer, Thomas P., Sander Bollen, Mar Rodríguez‐Girondo, et al.. (2020). Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma. Journal of Medical Genetics. 58(11). 760–766. 6 indexed citations

12.

Chau, Cindy, Remco van Doorn, Natasha M. van Poppelen, et al.. (2019). Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers. 11(8). 1114–1114. 39 indexed citations

13.

Potjer, Thomas P., Hildur Helgadóttir, Nienke van der Stoep, et al.. (2018). CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe. Journal of Medical Genetics. 55(10). 661–668. 11 indexed citations

14.

Potjer, Thomas P., Sander Bollen, Remco van Doorn, et al.. (2018). Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families. International Journal of Cancer. 144(10). 2453–2464. 28 indexed citations

15.

Suerink, Manon, Thomas P. Potjer, A. Birgitta Versluijs, et al.. (2017). Constitutional mismatch repair deficiency in a healthy child: On the spot diagnosis?. Clinical Genetics. 93(1). 134–137. 20 indexed citations

16.

Mulder, Babs G. Sibinga, J. Sven D. Mieog, Henricus J.M. Handgraaf, et al.. (2016). Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer. Journal of Clinical Pathology. 70(2). 174–178. 23 indexed citations

17.

Potjer, Thomas P., Bart Mertens, Simone Nicolardi, et al.. (2016). Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort. Translational Oncology. 9(3). 242–247. 9 indexed citations

18.

Potjer, Thomas P., Nienke van der Stoep, Jeanine J. Houwing‐Duistermaat, et al.. (2015). Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case–control study. BMC Research Notes. 8(1). 264–264. 10 indexed citations

19.

Pal, Aparna, Thomas P. Potjer, Soren K. Thomsen, et al.. (2015). Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans. Diabetes. 65(2). 527–533. 36 indexed citations

20.

Potjer, Thomas P., et al.. (2014). Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant. European Journal of Human Genetics. 23(5). 711–714. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact